Juvenile Arthritis Awareness Month: Juvenile idiopathic arthritis (JIA) is a long-lasting inflammatory condition that affects children under 16. It causes ongoing joint inflammation, pain, and stiffness, making it the most common type of arthritis in kids. Without treatment, JIA can seriously harm a child's quality of life by damaging joints, affecting growth, and reducing physical abilities.
Unlike adult arthritis, which is usually caused by joint wear and tear, JIA occurs when the immune system mistakenly attacks the body's own tissues. This autoimmune process can also affect the liver, eyes, skin, and other organs. Early diagnosis and proper treatment are crucial to managing symptoms and preventing long-term problems, says Dr Akhilesh Yadav, associate director of orthopaedics & joint replacement at Max hospital, Vaishali.
Causes of juvenile idiopathic arthritis
Juvenile idiopathic arthritis (JIA) is hard to understand and treat because the exact cause is unknown. However, experts believe it results from a combination of genetic factors and environmental triggers. Some genetic markers can increase the risk of developing JIA, leading to problems with the immune system and inflammation, says Dr Yadav.
In children with a genetic predisposition, events like infections or injuries might trigger the condition. Additionally, immune system abnormalities can cause inflammation, contributing to JIA. It's important to know that JIA is not contagious and cannot be prevented through vaccines or lifestyle changes, says Dr Yadav.
Risk factors for juvenile idiopathic arthritis
Genetic susceptibility: Family history of autoimmune illnesses is the most significant risk factor. Children with relatives who have autoimmune diseases (e.g., multiple sclerosis, lupus, rheumatoid arthritis) are more vulnerable.
Gender: Girls are more prone to developing JIA than boys. The reasons for this gender difference are not fully known.
Infections: Some infections may trigger JIA in genetically predisposed children.
Environmental factors: Exposure to specific toxins or pollutants may increase the risk of developing JIA.
Age: While JIA can occur at any age, it most commonly appears between the ages of 1 and 6.
Treatment options for juvenile idiopathic arthritis
According to Dr Yadav, the treatment of JIA is multidisciplinary and aims to relieve symptoms, prevent joint damage, and maintain function.
Medications
Nonsteroidal anti-inflammatory drugs (NSAIDs): Help reduce pain and inflammation.
Disease-modifying antirheumatic drugs (DMARDs): Slow the progression of the disease (e.g., methotrexate).
Biologic agents: Target specific components of the immune system (e.g., TNF inhibitors, IL-1 inhibitors).
Corticosteroids: Used for severe symptoms or during flare-ups to quickly reduce inflammation.
Physical therapy: Helps maintain joint function and muscle strength through exercise.
Occupational therapy: Assists children in adapting activities to minimise joint strain.
Lifestyle modifications: Includes a healthy diet, regular exercise, and proper rest.
Surgery: Rarely needed but may be considered in severe cases to repair or replace damaged joints.
It is necessary to handle juvenile idiopathic arthritis promptly and comprehensively because it is a difficult and possibly crippling illness. Even if the precise cause is still unknown, early diagnosis and intervention can be facilitated by knowledge of the genetic and environmental components involved.
Children diagnosed with juvenile onset autism can effectively control their symptoms and lead fulfilling lives with the right support and care. Hope for better results and better treatment of this chronic condition is being maintained by ongoing research and developments in medical therapies.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
